|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | (2013.01) |
| C07K 16/40 | (2006.01) | ||
| C07K 14/725 | (2006.01) | ||
| A61K 35/00 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C12N 9/16 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C12Y 301/03001 | (2013.01) | ||
| A61K 35/00 | (2006.01) | ||
| G01N 33/57407 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| C12N 9/16 | (2006.01) | ||
| A61K 47/6803 | (2017.08) | ||
| G01N 33/574 | (2006.01) | ||
| A61K 47/6871 | (2017.08) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3383920 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16871367.5 |
| Date of filing the European patent application | 2016-11-29 | |
| (97) | Date of publication of the European application | 2018-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/064033 |
| Date | 2016-11-29 |
| (87) | Number | WO 2017/095823 |
| Date | 2017-06-08 |
| (30) | Number | Date | Country code |
| 201562261112 P | 2015-11-30 | US |
| (72) |
LIU, Bin , US
BIDLINGMAIER, Scott , US
SU, Yang , US
|
| (73) |
The Regents of the University of California ,
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200,
US
|
| (54) | TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN |
| TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN |